Exodus Point Capital Management, LP Myriad Genetics Inc Transaction History

Exodus Point Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$17.98 - $25.47 $1.64 Million - $2.32 Million	91,221 Added 115.37%	170,287 $4.17 Million
Q1 2024 May 14, 2024	BUY	$17.59 - $23.59 $1.07 Million - $1.44 Million	61,106 Added 340.23%	79,066 $1.69 Million
Q3 2023 Nov 09, 2023	SELL	$15.99 - $23.22 $5.5 Million - $7.98 Million	-343,657 Reduced 95.03%	17,960 $288,000
Q2 2023 Aug 10, 2023	BUY	$17.56 - $23.76 $6.35 Million - $8.59 Million	361,617 New	361,617 $8.38 Million
Q4 2022 Feb 13, 2023	BUY	$14.51 - $20.99 $178,473 - $258,176	12,300 New	12,300 $178,000
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $466,865 - $740,609	-23,437 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.16 - $19.77 $284,993 - $463,349	23,437 New	23,437 $463,000
Q3 2020 Nov 16, 2020	SELL	$11.25 - $14.75 $414,438 - $543,375	-36,839 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$10.69 - $16.49 $393,808 - $607,475	36,839 New	36,839 $418,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.